Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 91


The human parasite Leishmania amazonensis downregulates iNOS expression via NF-κB p50/p50 homodimer: role of the PI3K/Akt pathway.

Calegari-Silva TC, Vivarini ÁC, Miqueline M, Dos Santos GR, Teixeira KL, Saliba AM, Nunes de Carvalho S, de Carvalho L, Lopes UG.

Open Biol. 2015 Sep;5(9):150118. doi: 10.1098/rsob.150118.


Focus on PTEN Regulation.

Bermúdez Brito M, Goulielmaki E, Papakonstanti EA.

Front Oncol. 2015 Jul 27;5:166. doi: 10.3389/fonc.2015.00166. eCollection 2015. Review.


Missense mutation in the PTEN promoter of a patient with hemifacial hyperplasia.

Yamazaki K, Eng C, Kuznetsov SA, Reinisch J, Yamashita DD, Walker J, Cheung C, Robey PG, Yen SL.

Bonekey Rep. 2015 Jul 29;4:654. doi: 10.1038/bonekey.2015.21. eCollection 2015.


The Unique Non-Catalytic C-Terminus of P37delta-PI3K Adds Proliferative Properties In Vitro and In Vivo.

Ejeskär K, Vickes O, Kuchipudi A, Wettergren Y, Uv A, Rotter Sopasakis V.

PLoS One. 2015 May 29;10(5):e0127497. doi: 10.1371/journal.pone.0127497. eCollection 2015.


PTEN Expression as a Predictor of Response to Focal Adhesion Kinase Inhibition in Uterine Cancer.

Thanapprapasr D, Previs RA, Hu W, Ivan C, Armaiz-Pena GN, Dorniak PL, Hansen JM, Rupaimoole R, Huang J, Dalton HJ, Ali-Fehmi R, Coleman RL, Sood AK.

Mol Cancer Ther. 2015 Jun;14(6):1466-75. doi: 10.1158/1535-7163.MCT-14-1077. Epub 2015 Apr 1.


Relevance and therapeutic possibility of PTEN-long in renal cell carcinoma.

Wang H, Zhang P, Lin C, Yu Q, Wu J, Wang L, Cui Y, Wang K, Gao Z, Li H.

PLoS One. 2015 Feb 25;10(2):e114250. doi: 10.1371/journal.pone.0114250. eCollection 2015.


Phospholipid-binding sites of phosphatase and tensin homolog (PTEN): exploring the mechanism of phosphatidylinositol 4,5-bisphosphate activation.

Wei Y, Stec B, Redfield AG, Weerapana E, Roberts MF.

J Biol Chem. 2015 Jan 16;290(3):1592-606. doi: 10.1074/jbc.M114.588590. Epub 2014 Nov 27.


Prevention of K-Ras- and Pten-mediated intravaginal tumors by treatment with camptothecin-loaded PLGA nanoparticles.

Blum JS, Weller CE, Booth CJ, Babar IA, Liang X, Slack FJ, Saltzman WM.

Drug Deliv Transl Res. 2011 Oct 1;1(5):383-394.


Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer.

Burger MT, Pecchi S, Wagman A, Ni ZJ, Knapp M, Hendrickson T, Atallah G, Pfister K, Zhang Y, Bartulis S, Frazier K, Ng S, Smith A, Verhagen J, Haznedar J, Huh K, Iwanowicz E, Xin X, Menezes D, Merritt H, Lee I, Wiesmann M, Kaufman S, Crawford K, Chin M, Bussiere D, Shoemaker K, Zaror I, Maira SM, Voliva CF.

ACS Med Chem Lett. 2011 Aug 26;2(10):774-9. doi: 10.1021/ml200156t. eCollection 2011 Oct 13.


Synthesis and in Vitro and in Vivo Evaluation of Phosphoinositide-3-kinase Inhibitors.

Burger MT, Knapp M, Wagman A, Ni ZJ, Hendrickson T, Atallah G, Zhang Y, Frazier K, Verhagen J, Pfister K, Ng S, Smith A, Bartulis S, Merrit H, Weismann M, Xin X, Haznedar J, Voliva CF, Iwanowicz E, Pecchi S.

ACS Med Chem Lett. 2010 Oct 13;2(1):34-8. doi: 10.1021/ml1001932. eCollection 2011 Jan 13.


Novel mechanism of tumor suppression by polarity gene discs large 1 (DLG1) revealed in a murine model of pediatric B-ALL.

Sandoval GJ, Graham DB, Gmyrek GB, Akilesh HM, Fujikawa K, Sammut B, Bhattacharya D, Srivatsan S, Kim A, Shaw AS, Yang-Iott K, Bassing CH, Duncavage E, Xavier RJ, Swat W.

Cancer Immunol Res. 2013 Dec;1(6):426-37. doi: 10.1158/2326-6066.CIR-13-0065. Epub 2013 Oct 7.


Cancer cell-oriented migration of mesenchymal stem cells engineered with an anticancer gene (PTEN): an imaging demonstration.

Yang ZS, Tang XJ, Guo XR, Zou DD, Sun XY, Feng JB, Luo J, Dai LJ, Warnock GL.

Onco Targets Ther. 2014 Mar 17;7:441-6. doi: 10.2147/OTT.S59227. eCollection 2014.


Salvianolic acid A positively regulates PTEN protein level and inhibits growth of A549 lung cancer cells.

Bi L, Chen J, Yuan X, Jiang Z, Chen W.

Biomed Rep. 2013 Mar;1(2):213-217. Epub 2012 Oct 29.


Functions and Regulation of the PTEN Gene in Colorectal Cancer.

Molinari F, Frattini M.

Front Oncol. 2014 Jan 16;3:326. doi: 10.3389/fonc.2013.00326. eCollection 2013. Review.


PGE2-driven expression of c-Myc and oncomiR-17-92 contributes to apoptosis resistance in NSCLC.

Krysan K, Kusko R, Grogan T, O'Hearn J, Reckamp KL, Walser TC, Garon EB, Lenburg ME, Sharma S, Spira AE, Elashoff D, Dubinett SM.

Mol Cancer Res. 2014 May;12(5):765-74. doi: 10.1158/1541-7786.MCR-13-0377. Epub 2014 Jan 27.


High expression of inositol polyphosphate phosphatase-like 1 associates with unfavorable survival in hepatocellular carcinoma.

Fu M, Gu X, Ni H, Zhang W, Chang F, Gong L, Chen X, Li J, Qiu L, Shi C, Bao J.

Int J Clin Exp Pathol. 2013 Oct 15;6(11):2515-22. eCollection 2013.


BAG5 regulates PTEN stability in MCF-7 cell line.

Ying Z, Haiyan G, Haidong G.

BMB Rep. 2013 Oct;46(10):490-4.


A new mathematical approach for qualitative modeling of the insulin-TOR-MAPK network.

Nijhout HF, Callier V.

Front Physiol. 2013 Sep 12;4:245. doi: 10.3389/fphys.2013.00245. eCollection 2013.


Analysis of PTEN expression in large intestine polyps and its relation to the recognized histopathological and clinical risk factors for cancer development in this location.

Waniczek D, Snietura M, Pigłowski W, Rdes J, Kopeć A, Młynarczyk-Liszka J, Rudzki M, Hudyka K, Arendt J, Lange D.

Contemp Oncol (Pozn). 2012;16(4):310-5. doi: 10.5114/wo.2012.30059. Epub 2012 Sep 29.


A secreted PTEN phosphatase that enters cells to alter signaling and survival.

Hopkins BD, Fine B, Steinbach N, Dendy M, Rapp Z, Shaw J, Pappas K, Yu JS, Hodakoski C, Mense S, Klein J, Pegno S, Sulis ML, Goldstein H, Amendolara B, Lei L, Maurer M, Bruce J, Canoll P, Hibshoosh H, Parsons R.

Science. 2013 Jul 26;341(6144):399-402. doi: 10.1126/science.1234907. Epub 2013 Jun 6.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk